New mouse model reminiscent of Leigh syndrome sheds light on mechanisms of neurodegeneration
Leuven researchers led by professor Bart De Strooper (VIB-KU Leuven) have identified a new role for PARL, a protein linked to Parkinson’s disease. In this week’s edition of the Proceedings of the National Academy of Science, they report that mice lacking PARL instead display specific problems in the nervous system reminiscent of Leigh syndrome.
PARL belongs to a family of evolutionary conserved intramembrane cleaving proteases, but it is the only member present in mitochondria. PARL has been implicated in diverse processes, and has even been linked to Parkinson’s disease, but its exact role in health and disease remains unclear.
Research from the lab of prof. Bart De Strooper (VIB-KU Leuven) now shows that PARL plays a crucial role in the nervous system. Mice in which PARL is absent specifically in the nervous system display a striking mitochondrial phenotype, reminiscent of Leigh syndrome.
Leigh syndrome is a mitochondrial disease characterized by severe neurodegeneration and caused by disrupted cellular energy production. The researchers found that mice without PARL, whether through a genetic deletion in all cells or only in cells of the nervous system, show symptoms similar to patients with Leigh syndrome.
“We saw a striking neurodegeneration in our PARL mouse model, which turned out not to be due to programmed cell death or apoptosis, but due to necrosis (a type of cell death that doesn’t follow the apoptotic signal transduction pathway),” says Dr. Marco Spinazzi, who dug further into the mechanisms leading to widespread effects in the brain.
“We found that, in the absence of PARL, necrosis in the brain is preceded by progressive mitochondrial structural changes and by defects in the mitochondrial respiratory chain. Interestingly, these effects were not mediated by the two cleavage substrates of PARL that have previously been linked to Parkinson’s disease. Although much caution is needed when extrapolating from mouse models to human diseases, this study prompts to investigate whether or not PARL gene mutations are present in human patients with unexplained Leigh disease or Leigh-like syndromes,” says Bart De Strooper.
Since the two Parkinson’s-linked substrates of PARL are not responsible for the Leigh-like pathology, scientists will now have to look for other biochemical mechanisms that could be involved.
“The reasons for the remarkable tissue specificity of the symptoms remains unclear for both mouse and human Leigh syndrome, as well as for most other major neurological diseases,” adds De Strooper. “This makes the findings in this mouse model particularly interesting.”
Source: Read Full Article